Human growth hormone treatment in prepubertal children with achondroplasia

American Journal of Medical Genetics

Volumn 61, Issue 4, 1996, Pages 396-400

  Weber, Giovanna ^a,b   Prinster, Chiara ^a   Meneghel, Marta ^a   Russo, Fiorella ^a   Mora, Stefano ^a   Puzzovio, Maria ^a   Maschio, Maurizia Del ^a   Chiumello, Giuseppe ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b H San Raffaele ^*  (Italy)

Author keywords

achondroplasia; growth hormone; growth velocity

Indexed keywords

GROWTH HORMONE;

ACHONDROPLASIA; ANTERIOR FONTANEL; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHILD; CLINICAL ARTICLE; FEMALE; GENETIC VARIABILITY; GROWTH RATE; HORMONAL THERAPY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREPUBERTY; PRIORITY JOURNAL; TURNER SYNDROME;

ACHONDROPLASIA; CHILD; CHILD, PRESCHOOL; FEMALE; GROWTH; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; PEPTIDE FRAGMENTS; PROCOLLAGEN; PUBERTY; THYROID GLAND;

EID: 0030020454     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19960202)61:4<396::AID-AJMG17>3.0.CO;2-N     Document Type: Article

References (27)

1. Aldegheri R, Trivella G, Renzi-Brivio L, Tessari G, Agostini S, Lavini F. (1988): Lengthening of the lower limbs in achondroplastic patients. J Bone Joint Surg 70-B:69-73.
2. Allen DB, Brook CGD, Bridges NA, Hindmarsh PC, Guyda HJ, Frazier D (1994): Therapeutic controversies: Growth hormone (GH) treatment of non-GH deficient subjects. J Clin Endocrinol Metab 79:1239-1248.
3. Appan S, Laurent S, Chapman M, Hindmarsh PC, Brook CGD (1990): Growth and growth hormone therapy in hypochondroplasia. Acta Paediatr Scand 79:796-803.
4. Bellus GA, Hefferon TW, Deluna RIO, Hecht JT, Horton WA, Machado M, Kaitila I, Mcintosh I, Francomano CA (1995): Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet 56:368-373.
5. Bridges NA, Hindmarsh PC, Brook CGD (1991): Growth of children with hypochondroplasia treated with growth hormone for up to three years. Horm Res 36 (suppl 1):56-60.
6. Francomano CA, Ortiz de Luna RI, Hefferon TW, Bellus GA, Turner CE, Taylor E, Meyers DA, Blanton SH, Murray JC, McIntosh I, Hecht JT (1994): Localization of the achondroplasia gene to the distal 2.5 Mb of human chromosome 4p. Hum Mol Genet 3:787-792.
7. Hecht JT, Horton WA, Reid CS, Pyeritz RE, Chakraborty R (1989): Growth of the foramen magnum in achondroplasia. Am J Med Genet 32:528-535.
8. Hindmarsh PC, Bridges NA, Brook CGD (1991): Wider indications for treatment with biosynthetic human growth hormone in children. Clin Endocrinol 34:417-427.
9. Horton WA, Hecht JT, Hood OJ, Marshall RN, Moore Wv, Hollowell JG (1992): Growth hormone therapy in achondroplasia. Am J Med Genet 42:667-670.
10. Kelley VC, Ruvalcaba RHA (1982): Use of anabolic agents in treatment of short children. Clin Endocrinol Metab 11:25-39.
11. Melkko J, Niemi S, Risteli L, Risteli J (1990): Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 36:1328-1332.
12. Le Merrer M, Rousseau F, Legeai-Mallet L, Landais JC, Pelet A, Bonaventure J, Sanak M, Weissenbach J, Stoll C, Munnich A, Maroteaux P (1994): A gene for achondroplasia-hypochondroplasia maps to chromosome 4p. Nature Genet 6:318-321.
13. Nishi Y, Kajiyama M, Niyagawa S, Fujiwara M, Hamamoto K (1993): Growth hormone therapy in achondroplasia. Acta Endocrinol 128:394-396.
14. Oberklaid F, Danks DM, Jensen F, Stace L, Rosshandler S (1979): Achondroplasia and hypochondroplasia: Comments on frequency, mutation rate, and radiological features in skull and spine. J Med Genet 16:140-146.
15. Okabe T, Nishikawa K, Miyamori C, Sato T (1991): Growth-promoting effect of human growth hormone on patients with achondroplasia. Acta Paediatr Jpn 33:357-362.
16. Rimoin D, Hughes G, Kawfman RL, Rosenthal RE, McAlister WH, Silberberg R (1970): Endochondral ossification in achondroplastic dwarfism. N Engl J Med 283:728-735.
17. Rongen-Westerlaken C, Wit JM, Drop SLS, Otten BJ, Oostdijk W, Delemarre-van der Waal HA, Gons MH, Bot A, Van den Brande JL (1988): Methionyl human growth hormone in Turner's Syndrome. Arch Dis Child 63:1211-1217.
18. Rosenfeld RG, Hintz RL, Johanson AJ, Sherman B, Brasel A, Burstein S, Chernausek S, Compton P, Frane J, Gotlan RW, Kuntze J, Lippe BM, Mahoney PC, Moore WV, New MI, Saenger P, Sybert V (1988): Three year results of a randomized prospective trial of methionyl growth hormone and oxandrolone in Turner Syndrome. J Pediatr 113:393-400.
19. Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet J-M, Maroteaux P, Le Merrer M, Munnich A (1994): Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature (London) 371:252-254.
20. Shiang R, Thompson LM, Zhu Y-Z, Church DM, Fielder TJ, Bocian M, Winokur ST, Wasmuth JJ (1994): Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78:335-342.
21. Stoilov I, Kilpatrick MW, Tsipouras P (1995): A common FGFR3 gene mutation is present in achondroplasia but not in hypochondroplasia. Am J Med Genet 55:127-133.
22. Stokes DC, Phillips JA, Leonard CO, Dorst JP, Kopits SE, Trojak JE, Brown DL (1983): Respiratory complications of achondroplasia. J Pediatr 102:534-540.
23. Tanner JM, Whitehouse GH, Cameron M (1975): "Assessment of Skeletal Maturity and Prediction of Adult Height (TW2 Method)." London: Academic Press.
24. Vanderschveren-Lodeweyckx M. Massa G. Maes M, Craen M, Van Vliet G, Heinrichs C, Malvaux P. (1990): Growth-promoting effect of growth hormone and low dose ethinyloestradiol in girls with Turner's Syndrome. J Clin Endocrinol Metab 70:122-126.
25. Velinov M, Slaugenhaupt SA, Stoilov I, Scott Jr. CI, Gusella JF, Tsipouras P (1994): The gene for achondroplasia maps to the telomeric region of chromosome 4p. Nature Genet 6:314-317.
26. Villarrubias JM, Ginebreda I, Jimeno E. (1990): Lengthening of the lower limbs and correction of lumbar hyperlordosis in achondroplasia. Clin Orthop Relat Res 250:143-149.
27. Yamate T, Kanazaki S, Tanaka H, Kubo T, Moriwake T, Inouc M, Seino Y (1993): Growth hormone (GH) treatment in achondroplasia. J Pediatr Endocrinol 6:45-52.